These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 25873280)
1. Abnormal expression of Forkhead Box J2 (FOXJ2) suppresses migration and invasion in extrahepatic cholangiocarcinoma and is associated with prognosis. Qiang Y; Wang F; Yan S; Zhang H; Zhu L; Chen Z; Tu F; Wang D; Wang G; Wang W; Chen Z Int J Oncol; 2015; 46(6):2449-58. PubMed ID: 25873280 [TBL] [Abstract][Full Text] [Related]
2. ANXA8 down-regulation by EGF-FOXO4 signaling is involved in cell scattering and tumor metastasis of cholangiocarcinoma. Lee MJ; Yu GR; Yoo HJ; Kim JH; Yoon BI; Choi YK; Kim DG Gastroenterology; 2009 Sep; 137(3):1138-50, 1150.e1-9. PubMed ID: 19376120 [TBL] [Abstract][Full Text] [Related]
3. The role of FoxJ2 in the migration of human glioma cells. Qiu X; Ji B; Yang L; Huang Q; Shi W; Ding Z; He X; Ban N; Fan S; Zhang J; Tian Y Pathol Res Pract; 2015 May; 211(5):389-97. PubMed ID: 25661068 [TBL] [Abstract][Full Text] [Related]
4. microRNA-34a inhibits epithelial mesenchymal transition in human cholangiocarcinoma by targeting Smad4 through transforming growth factor-beta/Smad pathway. Qiao P; Li G; Bi W; Yang L; Yao L; Wu D BMC Cancer; 2015 Jun; 15():469. PubMed ID: 26077733 [TBL] [Abstract][Full Text] [Related]
5. Overexpression of forkhead box J2 can decrease the migration of breast cancer cells. Wang Y; Yang S; Ni Q; He S; Zhao Y; Yuan Q; Li C; Chen H; Zhang L; Zou L; Shen A; Cheng C J Cell Biochem; 2012 Aug; 113(8):2729-37. PubMed ID: 22441887 [TBL] [Abstract][Full Text] [Related]
6. Forkhead box protein C2 contributes to invasion and metastasis of extrahepatic cholangiocarcinoma, resulting in a poor prognosis. Watanabe A; Suzuki H; Yokobori T; Altan B; Kubo N; Araki K; Wada S; Mochida Y; Sasaki S; Kashiwabara K; Hosouchi Y; Kuwano H Cancer Sci; 2013 Nov; 104(11):1427-32. PubMed ID: 23919841 [TBL] [Abstract][Full Text] [Related]
7. LncRNA-CCAT1 Promotes Migration, Invasion, and EMT in Intrahepatic Cholangiocarcinoma Through Suppressing miR-152. Zhang S; Xiao J; Chai Y; Du YY; Liu Z; Huang K; Zhou X; Zhou W Dig Dis Sci; 2017 Nov; 62(11):3050-3058. PubMed ID: 28921383 [TBL] [Abstract][Full Text] [Related]
8. The prognostic role and reduced expression of FOXJ2 in human hepatocellular carcinoma. Zhang Z; Meng G; Wang L; Ma Y; Guan Z Mol Med Rep; 2016 Jul; 14(1):254-62. PubMed ID: 27177166 [TBL] [Abstract][Full Text] [Related]
9. Overexpression of long noncoding RNA H19 indicates a poor prognosis for cholangiocarcinoma and promotes cell migration and invasion by affecting epithelial-mesenchymal transition. Xu Y; Wang Z; Jiang X; Cui Y Biomed Pharmacother; 2017 Aug; 92():17-23. PubMed ID: 28528181 [TBL] [Abstract][Full Text] [Related]
10. FOXJ2 Inhibits the Proliferation, Migration and Epithelial-Mesenchymal Transition of Prostate Carcinoma Cells. Guo G; Zhu L Ann Clin Lab Sci; 2022 Sep; 52(5):731-740. PubMed ID: 36261186 [TBL] [Abstract][Full Text] [Related]
11. ARHGAP9 suppresses the migration and invasion of hepatocellular carcinoma cells through up-regulating FOXJ2/E-cadherin. Zhang H; Tang QF; Sun MY; Zhang CY; Zhu JY; Shen YL; Zhao B; Shao ZY; Zhang LJ; Zhang H Cell Death Dis; 2018 Sep; 9(9):916. PubMed ID: 30206221 [TBL] [Abstract][Full Text] [Related]
12. Protein tyrosine phosphatase PTP4A1 promotes proliferation and epithelial-mesenchymal transition in intrahepatic cholangiocarcinoma via the PI3K/AKT pathway. Liu LZ; He YZ; Dong PP; Ma LJ; Wang ZC; Liu XY; Duan M; Yang LX; Shi JY; Zhou J; Fan J; Gao Q; Wang XY Oncotarget; 2016 Nov; 7(46):75210-75220. PubMed ID: 27655691 [TBL] [Abstract][Full Text] [Related]
13. Annexin10 promotes extrahepatic cholangiocarcinoma metastasis by facilitating EMT via PLA2G4A/PGE2/STAT3 pathway. Sun R; Liu Z; Qiu B; Chen T; Li Z; Zhang X; Xu Y; Zhang Z EBioMedicine; 2019 Sep; 47():142-155. PubMed ID: 31492557 [TBL] [Abstract][Full Text] [Related]
14. LncRNA FENDRR represses proliferation, migration and invasion through suppression of survivin in cholangiocarcinoma cells. Qin X; Lu M; Zhou Y; Li G; Liu Z Cell Cycle; 2019 Apr; 18(8):889-897. PubMed ID: 30983519 [TBL] [Abstract][Full Text] [Related]
15. miR-378 serves as a prognostic biomarker in cholangiocarcinoma and promotes tumor proliferation, migration, and invasion. Zhou Z; Ma J Cancer Biomark; 2019; 24(2):173-181. PubMed ID: 30594918 [TBL] [Abstract][Full Text] [Related]
16. Upregulated LASP-1 correlates with a malignant phenotype and its potential therapeutic role in human cholangiocarcinoma. Zhang H; Li Z; Chu B; Zhang F; Zhang Y; Ke F; Chen Y; Xu Y; Liu S; Zhao S; Liang H; Weng M; Wu X; Li M; Wu W; Quan Z; Liu Y; Zhang Y; Gong W Tumour Biol; 2016 Jun; 37(6):8305-15. PubMed ID: 26729195 [TBL] [Abstract][Full Text] [Related]
17. Downregulated circular RNA hsa_circ_0001649 regulates proliferation, migration and invasion in cholangiocarcinoma cells. Xu Y; Yao Y; Zhong X; Leng K; Qin W; Qu L; Cui Y; Jiang X Biochem Biophys Res Commun; 2018 Feb; 496(2):455-461. PubMed ID: 29337065 [TBL] [Abstract][Full Text] [Related]
18. Up-regulation of 14-3-3ζ expression in intrahepatic cholangiocarcinoma and its clinical implications. Zhang C; Liu LX; Dong ZR; Shi GM; Cai JB; Zhang PF; Ke AW; Yu JX; Zhou J; Fan J Tumour Biol; 2015 Mar; 36(3):1781-9. PubMed ID: 25391422 [TBL] [Abstract][Full Text] [Related]
19. Up-regulated LINC00261 predicts a poor prognosis and promotes a metastasis by EMT process in cholangiocarcinoma. Gao J; Qin W; Kang P; Xu Y; Leng K; Li Z; Huang L; Cui Y; Zhong X Pathol Res Pract; 2020 Jan; 216(1):152733. PubMed ID: 31812439 [TBL] [Abstract][Full Text] [Related]
20. MicroRNA-144 suppresses cholangiocarcinoma cell proliferation and invasion through targeting platelet activating factor acetylhydrolase isoform 1b. Yang R; Chen Y; Tang C; Li H; Wang B; Yan Q; Hu J; Zou S BMC Cancer; 2014 Dec; 14():917. PubMed ID: 25479763 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]